Numerai GP LLC Reduces Stake in Trupanion, Inc. (NASDAQ:TRUP)

Numerai GP LLC decreased its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 55.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,421 shares of the financial services provider's stock after selling 26,599 shares during the period. Numerai GP LLC owned about 0.05% of Trupanion worth $1,032,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of TRUP. Vanguard Group Inc. lifted its position in Trupanion by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock valued at $173,362,000 after purchasing an additional 45,653 shares in the last quarter. Marshall Wace LLP raised its stake in shares of Trupanion by 6.9% in the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider's stock worth $43,459,000 after buying an additional 57,804 shares during the period. Balyasny Asset Management L.P. lifted its position in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after buying an additional 661,559 shares in the last quarter. Baillie Gifford & Co. grew its stake in shares of Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after acquiring an additional 147,341 shares during the period. Finally, Northern Trust Corp grew its stake in shares of Trupanion by 9.0% during the 4th quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock valued at $17,749,000 after acquiring an additional 30,549 shares during the period.

Insiders Place Their Bets

In related news, insider Brenna Mcgibney sold 5,000 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.99, for a total value of $164,950.00. Following the sale, the insider now directly owns 3,738 shares in the company, valued at approximately $123,316.62. The trade was a 57.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Margaret Tooth sold 2,294 shares of the stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total value of $72,008.66. Following the transaction, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at approximately $3,728,629.76. The trade was a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,792 shares of company stock worth $1,122,802 in the last 90 days. 5.42% of the stock is currently owned by corporate insiders.

Trupanion Price Performance

TRUP traded up $1.34 during trading on Friday, reaching $46.77. 725,875 shares of the company traded hands, compared to its average volume of 614,484. The company has a market cap of $2.00 billion, a P/E ratio of -203.35, a PEG ratio of 6.02 and a beta of 1.72. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90. The firm has a fifty day simple moving average of $37.96 and a 200 day simple moving average of $44.27.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02. The firm had revenue of $341.98 million during the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. Trupanion's revenue for the quarter was up 11.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.16) earnings per share. On average, equities analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analyst Weigh In

TRUP has been the topic of a number of recent analyst reports. Lake Street Capital decreased their target price on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Piper Sandler decreased their price objective on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Finally, Stifel Nicolaus lowered their target price on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Trupanion has an average rating of "Moderate Buy" and an average target price of $51.80.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.